60 Degrees Pharmaceuticals
SXTP
7 hedge funds and large institutions have $62.9K invested in 60 Degrees Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
74% more capital invested
Capital invested by funds: $36.1K → $62.9K (+$26.8K)
40% more funds holding
Funds holding: 5 → 7 (+2)
0% more ownership
Funds ownership: 1.03% → 1.04% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$38.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.22K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$823 |
| 4 |
Citigroup
New York
|
+$286 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$104 |
SXTP Hedge Fund Activity: Q3 2025 in Review
7 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q3 2025, worth a combined $62.9K — up 74% from $36.1K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SXTP positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $38.4K. The largest seller was Geode Capital Management, cutting an estimated $104.
- 7 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q3 2025, up from 5 in Q2 2025.
- Funds reported $62.9K of 60 Degrees Pharmaceuticals stock for Q3 2025, up 74% quarter-over-quarter.
- 2 funds opened new 60 Degrees Pharmaceuticals positions in Q3 2025 and 0 closed out, a net change of +2 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q3 2025 was DRW Securities, an estimated $38.4K added.
- The largest 60 Degrees Pharmaceuticals seller in Q3 2025 was Geode Capital Management, an estimated $104 sold.
Based on aggregated 13F filings for Q3 2025.